Register
Login:
Share:
Email Facebook Twitter

RNS VIDEO: Reabold Resources #RBD raise £6 million and take stake in Danube Petroleum Watch here

EXCLUSIVE: HemoGenyx are creating blood cancer treatments with US$9 billion market potential


ShareCast News


Advanced Oncotherapy strikes China deal and raises 37m

Thu, 7th Dec 2017 08:45


(ShareCast News) - Advanced Oncotherapy shares surged after the cancer therapy specialist announced a distribution agreement for Greater China and South Korea and more than 37m in new funding.



The company said Yantai CIPU Medical Technology, a Chinese investor in the health industry, agreed to pay 16.5m to market and sell its LIGHT proton accelerator system.

Yantai will also buy 45m shares in Advanced Oncotherapy at 30p each, raising 13.5m. Other investors, including board members and debt holders will acquire shares on the same basis for a further 7.4m. The total funds raised will be 37.4m.

The shares had jumped 66% to 54.75p by 09:26 GMT on Thursday.

Advanced Oncotherapy develops proton treatments for cancer, which target a cancerous tumour more effectively than traditional radiation treatments with less damage to other parts of the body. LIGHT is the company's latest proton accelerator, which it says is cheaper, more precise and smaller than previous versions.

Nicolas Serandour, Advanced Oncotherapy's chief executive, said: "I am delighted that we have been able to conclude deals to provide shareholders not only with the security of longer-term financing, but which also introduce a new experienced strategic investor with strong distribution capacity and already established commercial interest in Asia, particularly in one of our key target markets, China.

Yantai, owned by the wealthy Han family, has identified eleven potential sites for installing LIGHT. The companies are aiming for three installations over the next four years and financing of 10 more. Yantai's Zhang RenHua and Chunlin Han will join Advanced Oncotherapy's board.





Back to ShareCast News


Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk




Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.